申请人:Otsuka Pharmaceutical Co., Ltd.
公开号:US05185337A1
公开(公告)日:1993-02-09
There is described pyrroloquinoline derivatives of general formula: ##STR1## wherein R' is a C.sub.1 -C.sub.6 alkyl group, R.sup.2 is a group: ##STR2## or group: ##STR3## wherein R.sup.3, R.sup.4, R.sup.5 and R.sup.6 are as defined, or salt thereof. These compounds have an antimicrobial activity.
通用公式描述了吡咯喹啉衍生物:##STR1## 其中R'是C.sub.1 -C.sub.6烷基基团,R.sup.2是一个基团:##STR2## 或基团:##STR3## 其中R.sup.3、R.sup.4、R.sup.5和R.sup.6如定义,或其盐。这些化合物具有抗微生物活性。